NASDAQ Composite Index
23.214,69
PKT
+189,10
PKT
+0,82
%
Werbung
Analysen zu NASDAQ Composite Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.03.11 | VeriSign outperform | Credit Suisse Group | |
| 01.03.11 | Gilead Sciences equal-weight | Barclays Capital | |
| 28.02.11 | Amazon neutral | UBS AG | |
| 28.02.11 | Deckers Outdoor overweight | Barclays Capital | |
| 28.02.11 | Autodesk overweight | Barclays Capital | |
| 28.02.11 | Salesforce hold | Citigroup Corp. | |
| 28.02.11 | Salesforce overweight | Piper Jaffray & Co. | |
| 25.02.11 | Autodesk neutral | Credit Suisse Group | |
| 25.02.11 | Applied Materials buy | Stifel, Nicolaus & Co., Inc. | |
| 25.02.11 | Salesforce buy | Stifel, Nicolaus & Co., Inc. | |
| 28.02.11 | NVIDIA halten | Nasd@q Inside | |
| 25.02.11 | Applied Materials neutral | Credit Suisse Group | |
| 25.02.11 | Salesforce neutral | Credit Suisse Group | |
| 25.02.11 | Garmin equal-weight | Barclays Capital | |
| 25.02.11 | NVIDIA kaufen | Der Aktionär | |
| 25.02.11 | Vertex Pharmaceuticals hold | ThinkEquity Partners LLC | |
| 25.02.11 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 24.02.11 | Vertex Pharmaceuticals hold | ThinkEquity Partners LLC | |
| 24.02.11 | Garmin neutral | Wedbush Morgan Securities Inc. | |
| 24.02.11 | Garmin sector perform | RBC Capital Markets | |
| 24.02.11 | Gilead Sciences outperform | RBC Capital Markets | |
| 25.02.11 | Vertex Pharmaceuticals overweight | Piper Jaffray & Co. | |
| 28.02.11 | Biogen outperform | RBC Capital Markets | |
| 24.02.11 | Autodesk overweight | Barclays Capital | |
| 24.02.11 | Apple overweight | Barclays Capital | |
| 25.02.11 | Vertex Pharmaceuticals buy | Goldman Sachs Group Inc. | |
| 24.02.11 | Myriad Genetics sell | Goldman Sachs Group Inc. | |
| 23.02.11 | Amedisys outperform | Oppenheimer & Co. Inc. | |
| 23.02.11 | Zions Bancorporation neutral | Credit Suisse Group | |
| 23.02.11 | Autodesk neutral | Credit Suisse Group | |
| 23.02.11 | eBay outperform | Credit Suisse Group | |
| 23.02.11 | Amedisys sector perform | RBC Capital Markets | |
| 23.02.11 | Amazon buy | UBS AG | |
| 23.02.11 | Salesforce neutral | Credit Suisse Group | |
| 23.02.11 | Regeneron Pharmaceuticals hold | Stifel, Nicolaus & Co., Inc. | |
| 23.02.11 | United Therapeutics buy | Stifel, Nicolaus & Co., Inc. | |
| 25.02.11 | Applied Materials overweight | Piper Jaffray & Co. | |
| 23.02.11 | Applied Materials overweight | Barclays Capital | |
| 23.02.11 | QUALCOMM outperform | Sanford C. Bernstein and Co., Inc. | |
| 23.02.11 | Netflix overweight | Piper Jaffray & Co. |